The drugmaker may have only used partial data when it announced the results from a U.S. trial of its coronavirus vaccine, the National Institutes of Health's allergy and infectious diseases institute said Tuesday. It called on the AstraZeneca to release updated information as soon as possible. |
No comments:
Post a Comment